143 related articles for article (PubMed ID: 15678792)
1. Prisoners are at risk for hepatitis C transmission.
Butler T; Kariminia A; Levy M; Kaldor J
Eur J Epidemiol; 2004; 19(12):1119-22. PubMed ID: 15678792
[TBL] [Abstract][Full Text] [Related]
2. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
4. Acquiring hepatitis C in prison: the social organisation of injecting risk.
Treloar C; McCredie L; Lloyd AR;
Harm Reduct J; 2015 Apr; 12():10. PubMed ID: 25903401
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of hepatitis C incidence in Australian prisoners.
Luciani F; Bretaña NA; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR;
Addiction; 2014 Oct; 109(10):1695-706. PubMed ID: 24916002
[TBL] [Abstract][Full Text] [Related]
6. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities.
Hellard ME; Hocking JS; Crofts N
Epidemiol Infect; 2004 Jun; 132(3):409-15. PubMed ID: 15188710
[TBL] [Abstract][Full Text] [Related]
7. Spread of bloodborne viruses among Australian prison entrants.
Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
[TBL] [Abstract][Full Text] [Related]
8. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J;
J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway.
Holsen DS; Harthug S; Myrmel H
Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):673-6. PubMed ID: 7694850
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey.
Long J; Allwright S; Barry J; Reynolds SR; Thornton L; Bradley F; Parry JV
BMJ; 2001 Nov; 323(7323):1209-13. PubMed ID: 11719410
[TBL] [Abstract][Full Text] [Related]
12. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
[TBL] [Abstract][Full Text] [Related]
14. Violence and hepatitis C transmission in prison-A modified social ecological model.
Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L
PLoS One; 2020; 15(12):e0243106. PubMed ID: 33259565
[TBL] [Abstract][Full Text] [Related]
15. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
Poulin C; Courtemanche Y; Serhir B; Alary M
Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and incidence of bloodborne viral infections among Danish prisoners.
Christensen PB; Krarup HB; Niesters HG; Norder H; Georgsen J
Eur J Epidemiol; 2000; 16(11):1043-9. PubMed ID: 11421474
[TBL] [Abstract][Full Text] [Related]
17. Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting.
Lafferty L; Rance J; Treloar C
Drug Alcohol Depend; 2018 Feb; 183():96-101. PubMed ID: 29245104
[TBL] [Abstract][Full Text] [Related]
18. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.
van Beek I; Dwyer R; Dore GJ; Luo K; Kaldor JM
BMJ; 1998 Aug; 317(7156):433-7. PubMed ID: 9703523
[TBL] [Abstract][Full Text] [Related]
19. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010.
Reekie JM; Levy MH; Richards AH; Wake CJ; Siddall DA; Beasley HM; Kumar S; Butler TG
Med J Aust; 2014 Mar; 200(5):277-80. PubMed ID: 24641153
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
Silverman-Retana O; Serván-Mori E; McCoy SI; Larney S; Bautista-Arredondo S
Drug Alcohol Depend; 2017 Dec; 181():140-145. PubMed ID: 29054033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
